3. 结构
3.1 二维结构
3.2 三维结构
-1
-2
-3
24 25 0 0 0 0 0 0 0999 V2000
0.2668 2.7591 0.8189 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.8259 2.1895 -1.0912 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.3463 -0.6395 0.0416 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.0883 0.3661 0.5325 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.3629 0.0123 0.4093 N 0 0 0 0 0 0 0 0 0 0 0 0
0.0376 -0.5766 0.0260 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7015 0.6448 -0.0884 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8261 -0.5022 -0.0016 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0957 0.6819 -0.1021 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7679 -1.7608 0.1266 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1621 -1.7236 0.1128 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3169 -0.4631 -0.0158 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1225 -1.6631 -0.4077 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0275 1.9032 -0.1960 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.4011 -1.2280 -0.1648 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6174 1.6318 -0.1969 H 0 0 0 0 0 0 0 0 0 0 0 0
0.2873 -2.7295 0.2353 H 0 0 0 0 0 0 0 0 0 0 0 0
2.7201 -2.6526 0.1942 H 0 0 0 0 0 0 0 0 0 0 0 0
4.6839 -0.5052 -1.0460 H 0 0 0 0 0 0 0 0 0 0 0 0
4.6912 0.4528 0.4541 H 0 0 0 0 0 0 0 0 0 0 0 0
4.7412 -1.3051 0.5416 H 0 0 0 0 0 0 0 0 0 0 0 0
-1.7430 -2.5695 -0.8587 H 0 0 0 0 0 0 0 0 0 0 0 0
-4.3321 -1.7325 -0.3740 H 0 0 0 0 0 0 0 0 0 0 0 0
-0.2273 3.6029 0.7398 H 0 0 0 0 0 0 0 0 0 0 0 0
1 14 1 0 0 0 0
1 24 1 0 0 0 0
2 14 2 0 0 0 0
3 4 1 0 0 0 0
3 6 1 0 0 0 0
3 13 1 0 0 0 0
4 5 2 0 0 0 0
5 15 1 0 0 0 0
6 7 2 0 0 0 0
6 10 1 0 0 0 0
7 9 1 0 0 0 0
7 14 1 0 0 0 0
8 9 2 0 0 0 0
8 11 1 0 0 0 0
8 12 1 0 0 0 0
9 16 1 0 0 0 0
10 11 2 0 0 0 0
10 17 1 0 0 0 0
11 18 1 0 0 0 0
12 19 1 0 0 0 0
12 20 1 0 0 0 0
12 21 1 0 0 0 0
13 15 2 0 0 0 0
13 22 1 0 0 0 0
15 23 1 0 0 0 0
4. 国际命名与标识
4.1 IUPAC Name
5-methyl-2-(triazol-1-yl)benzoic acid
4.2 InChl
InChI=1S/C10H9N3O2/c1-7-2-3-9(8(6-7)10(14)15)13-5-4-11-12-13/h2-6H,1H3,(H,14,15)
4.3 InChlKey
HWTWJXWEWOBHPS-UHFFFAOYSA-N
4.4 Canonical SMILES
CC1=CC(=C(C=C1)N2C=CN=N2)C(=O)O
4.5 lsomeric SMILES
-
4.6 SDF文件
5. 波谱数据
5.1 13C核磁共振谱(13C NMR)
5.2 1H核磁共振谱(1H NMR)
5.3 质谱(MS)
5.4 红外光谱(IR)
5.5 紫外/可见光谱(UV/Vis)
6. 相关药材
7. 相关靶点
8. 相关疾病